Which of the following adverse effects is characteristically associated with methysergide?
Which of the following effects is NOT caused by anticholinergics?
Which of the following drug classes does not cause mydriasis?
What is the typical concentration of adrenaline used with lignocaine?
Ocular effects that include mydriasis and fixed far vision are characteristic of which drug class?
All of the following are established uses of Prostaglandin E (PGE) EXCEPT:
In which of the following categories are ephedrine, tyramine, and amphetamine classified?
Atropine poisoning causes all of the following, except:
Which of the following is a selective beta-2 blocker?
What is the extent of nicotinic receptor blockade required for neuromuscular transmission failure due to non-depolarizing neuromuscular blockers?
Explanation: **Explanation:** **Methysergide** is an ergot derivative that acts as a potent 5-HT₂ receptor antagonist. While historically used for the prophylaxis of migraine and cluster headaches, its clinical utility is severely limited by a unique and serious adverse effect profile. **Why Retroperitoneal Fibrosis is Correct:** The hallmark toxicity of long-term methysergide therapy is **proliferative connective tissue reactions**. The most characteristic of these is **retroperitoneal fibrosis**, which can lead to ureteral obstruction and hydronephrosis. It can also cause pleuropulmonary fibrosis and subendocardial fibrosis (valvular heart disease). The mechanism is thought to involve chronic stimulation of 5-HT₂B receptors, which promotes fibroblast proliferation. **Analysis of Incorrect Options:** * **A. Pulmonary hypertension:** While some ergot alkaloids and serotonergic drugs (like fenfluramine) are linked to pulmonary hypertension, methysergide is specifically associated with *pleuropulmonary fibrosis* rather than isolated vascular hypertension. * **C. Hepatotoxicity:** Methysergide is not known for causing significant liver injury; its primary toxicities are fibrotic and vascular. * **D. Ischemic heart disease:** Although methysergide can cause vasoconstriction (ergotism), it is not the *characteristic* adverse effect tested in this context. Retroperitoneal fibrosis is the "classic" board-exam association. **High-Yield Clinical Pearls for NEET-PG:** * **Drug Holiday:** To prevent fibrosis, methysergide requires a "drug holiday" of 3–4 weeks every 6 months of treatment. * **5-HT₂B Connection:** Drugs that activate 5-HT₂B receptors (e.g., Methysergide, Pergolide, Fenfluramine) are notorious for causing valvular and fibrotic lesions. * **Carcinoid Syndrome:** Methysergide is also used to manage diarrhea and malabsorption in patients with carcinoid syndrome.
Explanation: **Explanation:** Anticholinergics (Muscarinic antagonists like Atropine) work by competitively blocking the action of acetylcholine at muscarinic receptors ($M_1$ to $M_5$) [2]. To identify the correct answer, one must understand the "Dry and Fast" physiological profile of these drugs. **1. Why Bronchoconstriction is the Correct Answer:** Bronchoconstriction is mediated by the **Parasympathetic** nervous system via **$M_3$ receptors** on bronchial smooth muscle. Anticholinergics block these receptors, leading to **Bronchodilation** and a reduction in secretions [1]. Therefore, bronchoconstriction is an effect of cholinergic agonists (like Methacholine), not anticholinergics. This is why Ipratropium and Tiotropium are used in treating Asthma and COPD. **2. Analysis of Incorrect Options:** * **Tachycardia (A):** Anticholinergics block **$M_2$ receptors** at the SA node, removing the vagal "brake" on the heart, which increases the heart rate [3]. * **Mydriasis (B):** Blockade of **$M_3$ receptors** on the pupillary sphincter muscle leads to passive dilation (mydriasis) and paralysis of accommodation (cycloplegia) [1]. * **Constipation (D):** Anticholinergics decrease gastrointestinal motility and secretions by blocking **$M_3$ receptors** in the gut, leading to constipation. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Atropine Toxicity:** "Hot as a hare, Red as a beet, Dry as a bone, Blind as a bat, Mad as a hatter." * **Drug of Choice:** Atropine is the DOC for **Symptomatic Bradycardia** and **Organophosphate Poisoning**. * **Contraindication:** Anticholinergics are strictly contraindicated in patients with **Angle-closure Glaucoma** and **Benign Prostatic Hyperplasia (BPH)**.
Explanation: **Explanation:** The size of the pupil is controlled by two muscles in the iris: the **Sphincter pupillae** (parasympathetic control via M3 receptors) and the **Dilator pupillae** (sympathetic control via α1 receptors). **Why Cholinergic Agonists are the correct answer:** Cholinergic agonists (e.g., Pilocarpine, Physostigmine) stimulate the **M3 receptors** on the Sphincter pupillae. This causes the muscle to contract, resulting in **Miosis** (pupillary constriction), not mydriasis. These drugs also cause contraction of the ciliary muscle, leading to accommodation for near vision and decreased intraocular pressure. **Analysis of Incorrect Options:** * **Anticholinergics (e.g., Atropine, Tropicamide):** These block M3 receptors on the sphincter muscle. By inhibiting the constrictor mechanism, the dilator muscle acts unopposed, resulting in **passive mydriasis**. * **Alpha-adrenergic agonists (e.g., Phenylephrine):** These directly stimulate **α1 receptors** on the Dilator pupillae, causing **active mydriasis** without affecting the ciliary muscle (no cycloplegia). * **Mydriatics:** This is a functional class of drugs specifically defined by their ability to induce pupillary dilation (mydriasis). **NEET-PG High-Yield Pearls:** 1. **Mydriasis + Cycloplegia:** Caused by Anticholinergics (Atropine is the longest-acting; Tropicamide is the shortest-acting). 2. **Mydriasis without Cycloplegia:** Caused by Phenylephrine (α1 agonist). 3. **Drug of choice for Acute Angle Closure Glaucoma:** Pilocarpine (Cholinergic agonist) to induce miosis and open the canal of Schlemm. 4. **Adrenaline in Glaucoma:** It causes mydriasis but *decreases* IOP by increasing uveoscleral outflow (via β receptors) and decreasing aqueous production (via α receptors).
Explanation: **Explanation:** The addition of **Adrenaline (Epinephrine)** to local anesthetics like Lignocaine is a standard clinical practice based on the principle of **local vasoconstriction**. **1. Why 1:200,000 is correct:** The standard concentration used for infiltration anesthesia is **1:200,000** (which equals 5 micrograms/mL). This concentration is high enough to stimulate alpha-1 receptors, causing localized vasoconstriction. This results in: * **Prolonged duration of action:** Reduced blood flow keeps the lignocaine at the nerve site longer. * **Reduced systemic toxicity:** Slower absorption into the bloodstream lowers the risk of systemic side effects. * **Bloodless field:** Useful for minor surgical procedures. **2. Analysis of Incorrect Options:** * **0.5% (A):** This is a massive dose (5 mg/mL). Adrenaline is never used in percentage concentrations for clinical procedures; it would cause severe tissue necrosis and cardiac arrhythmias. * **1:10,000 (B):** This is the concentration used in **Cardiac Arrest** (IV/Intracardiac). It is far too potent for local infiltration and would cause localized ischemia. * **1:20,000 (C):** This concentration is sometimes used in dental cartridges (1:80,000 to 1:100,000), but 1:20,000 is still excessively high for routine surgical lignocaine mixtures. **High-Yield Clinical Pearls for NEET-PG:** * **Maximum Dose:** The maximum dose of Lignocaine increases from **3 mg/kg** (plain) to **7 mg/kg** when combined with Adrenaline. * **Contraindications:** Never use Adrenaline with local anesthetics in **end-artery areas** (fingers, toes, nose, ear lobes, and penis) due to the risk of gangrene. * **pH Factor:** Adrenaline is acidic; adding it to lignocaine can make the injection more painful. Sodium bicarbonate is sometimes added to neutralize the pH.
Explanation: **Explanation:** The correct answer is **Mecamylamine**. This drug is a **ganglionic blocker** (Nn receptor antagonist) [1]. **1. Why Mecamylamine is correct:** Ganglionic blockers inhibit both sympathetic and parasympathetic transmission at the autonomic ganglia [4]. The resulting effect on an organ depends on which division of the ANS provides the **predominant basal tone** [1]. * **Ciliary Muscle:** The predominant tone is parasympathetic (constriction for near vision). Blocking this leads to relaxation of the ciliary muscle, causing **cycloplegia** (loss of accommodation) and **fixed far vision** [5]. * **Iris Sphincter:** The predominant tone is parasympathetic (miosis). Blocking this leads to passive **mydriasis** (dilation). The combination of mydriasis and fixed far vision is a hallmark of ganglionic blockade [3]. **2. Why other options are incorrect:** * **Neostigmine:** An acetylcholinesterase inhibitor that increases ACh levels, leading to **miosis** and spasm of accommodation (near vision), the opposite of the question's description. * **Phentolamine:** An alpha-blocker. While it can cause mild miosis (by blocking alpha-1 receptors on the dilator pupillae), it has **no effect on the ciliary muscle** or accommodation [2]. * **Phenylephrine:** An alpha-1 agonist. It causes **active mydriasis** but does not affect the ciliary muscle (no cycloplegia); therefore, accommodation remains intact [2]. **Clinical Pearls for NEET-PG:** * **Predominant Tone Rule:** Most organs are dominated by the Parasympathetic system (Heart, GI, Bladder, Eye). The exceptions dominated by the **Sympathetic** system are **Blood Vessels** (vasodilation occurs with blockers) and **Sweat Glands** [1]. * Mecamylamine is one of the few ganglionic blockers that crosses the blood-brain barrier. * **High-Yield Distinction:** Atropine (Antimuscarinic) also causes mydriasis and cycloplegia, but Mecamylamine is the classic ganglionic blocker example used to test the "predominant tone" concept [3].
Explanation: **Explanation:** The correct answer is **C. Induction of puberty**. Prostaglandins (PGs) are lipid-derived autacoids that play diverse roles in smooth muscle contraction, vascular tone, and cytoprotection, but they have no physiological or clinical role in the hormonal regulation of puberty. Puberty is initiated by the activation of the Hypothalamic-Pituitary-Gonadal (HPG) axis and the pulsatile release of GnRH. **Analysis of Options:** * **A. Erectile dysfunction:** **Alprostadil (PGE1)** is used as a second-line treatment. It can be administered via intracavernosal injection or intraurethral suppository. It works by increasing cAMP, leading to smooth muscle relaxation and vasodilation of the corpora cavernosa. * **B. Induction of labor:** **Dinoprostone (PGE2)** is a potent oxytocic agent used for cervical ripening and induction of labor. It softens the cervix and stimulates uterine contractions. Additionally, **Misoprostol (PGE1 analog)** is frequently used for medical abortion and labor induction. * **D. Patent ductus arteriosus (PDA):** In neonates with cyanotic heart disease (e.g., Transposition of Great Arteries), **Alprostadil (PGE1)** infusion is used to **maintain patency** of the ductus arteriosus until surgery can be performed. (Conversely, NSAIDs like Indomethacin are used to *close* a PDA). **High-Yield Clinical Pearls for NEET-PG:** * **PGE1 (Alprostadil):** Used for PDA maintenance and ED. * **PGE1 (Misoprostol):** Used for NSAID-induced peptic ulcers and medical abortion (combined with Mifepristone). * **PGE2 (Dinoprostone):** Primary agent for cervical ripening. * **PGF2α (Latanoprost):** First-line for Glaucoma (increases uveoscleral outflow). * **PGF2α (Carboprost):** Used for Postpartum Hemorrhage (PPH). * **PGI2 (Epoprostenol):** Used in Pulmonary Arterial Hypertension.
Explanation: ### Explanation **Correct Option: C. Indirect acting sympathomimetics** Sympathomimetics are drugs that mimic the effects of the sympathetic nervous system. They are classified based on their mechanism of action: * **Indirect acting sympathomimetics** do not act directly on the adrenergic receptors ($\alpha$ or $\beta$). Instead, they increase the concentration of endogenous norepinephrine (NE) in the synaptic cleft. * **Mechanism:** **Amphetamine** and **Tyramine** enter the presynaptic nerve terminal via the reuptake transporter (NET) and displace NE from storage vesicles into the synapse. **Ephedrine** is often classified as a **mixed-acting** agent because it both displaces NE (indirect) and directly stimulates receptors. However, in the context of this classification, it is grouped with indirect agents due to its significant NE-releasing effect. --- ### Why the other options are incorrect: * **A. Anticholinesterases:** These drugs (e.g., Neostigmine, Physostigmine) inhibit the enzyme acetylcholinesterase, leading to increased levels of acetylcholine. They affect the parasympathetic system, not the sympathetic system. * **B. Alpha-adrenergic blocking agents:** These drugs (e.g., Phentolamine, Prazosin) antagonize $\alpha$-receptors, leading to vasodilation and a decrease in blood pressure, which is the opposite effect of sympathomimetics. * **D. Direct acting sympathomimetics:** These drugs (e.g., Epinephrine, Norepinephrine, Phenylephrine) bind directly to and activate $\alpha$ and/or $\beta$ adrenoceptors. --- ### NEET-PG High-Yield Pearls: 1. **Tachyphylaxis:** Indirect acting sympathomimetics (especially Ephedrine and Amphetamine) show tachyphylaxis (rapidly diminishing response) because they deplete the stores of endogenous NE. 2. **The "Cheese Reaction":** Tyramine is found in fermented foods (aged cheese, red wine). Normally metabolized by MAO-A, it can cause a hypertensive crisis in patients taking MAO inhibitors. 3. **Amphetamine Clinical Use:** It is a CNS stimulant used in ADHD and Narcolepsy. 4. **Cocaine:** Unlike amphetamine, cocaine is an indirect sympathomimetic that works by **inhibiting the reuptake** of NE (NET inhibition) rather than displacing it.
Explanation: **Explanation:** Atropine is a classic **competitive muscarinic antagonist**. It works by blocking the action of acetylcholine at muscarinic receptors throughout the body. To remember the clinical features of atropine poisoning, students often use the mnemonic: *"Dry as a bone, Red as a beet, Hot as a hare, Blind as a bat, and Mad as a hatter."* **Why "Excessive Salivation" is the correct answer:** Muscarinic receptors (specifically $M_3$) are responsible for stimulating exocrine gland secretions. Atropine blocks these receptors, leading to a **marked decrease** in secretions. This results in a **dry mouth (xerostomia)** and difficulty swallowing, rather than excessive salivation. Therefore, excessive salivation is the "except" in this list. **Analysis of Incorrect Options:** * **Dilated pupil (Mydriasis):** Atropine blocks $M_3$ receptors on the pupillary sphincter muscle, leading to unopposed alpha-adrenergic action. This causes passive mydriasis and cycloplegia (loss of accommodation). * **Excitement:** Atropine crosses the blood-brain barrier. In toxic doses, it causes CNS stimulation, leading to restlessness, disorientation, hallucinations, and "atropine psychosis." * **Hot skin:** Atropine inhibits sweat gland activity (sympathetic cholinergic fibers). This impairs thermoregulation, leading to hyperthermia and dry, flushed skin. **NEET-PG High-Yield Pearls:** * **Drug of Choice for Atropine Poisoning:** **Physostigmine** (a tertiary amine anticholinesterase that crosses the BBB). * **Early Sign:** Dryness of the mouth is often the earliest sign of atropine action. * **Contraindication:** Atropine is strictly contraindicated in patients with **Angle-closure Glaucoma** and **Prostatic Hypertrophy**.
Explanation: **Explanation:** The correct answer is **Butoxamine**. **1. Why Butoxamine is correct:** Butoxamine is a selective **Beta-2 adrenergic receptor antagonist**. Unlike most clinically used beta-blockers which target Beta-1 receptors to manage cardiovascular conditions, Butoxamine specifically blocks Beta-2 receptors. It has no significant clinical therapeutic use but is extensively used in **pharmacological research** to identify and characterize beta-receptor subtypes. **2. Why the other options are incorrect:** * **Betaxolol, Esmolol, and Bisoprolol** are all **Cardioselective (Beta-1) blockers**. * **Esmolol:** Known for its ultra-short duration of action (half-life ~9 minutes) due to metabolism by RBC esterases; used in hypertensive emergencies and arrhythmias. * **Bisoprolol:** A highly selective Beta-1 blocker commonly used in the long-term management of heart failure and hypertension. * **Betaxolol:** A selective Beta-1 blocker often used topically in glaucoma to reduce intraocular pressure. **3. High-Yield NEET-PG Pearls:** * **Mnemonic for Beta-1 Selectives:** "New Beta Blockers Act Exclusively At My Heart" (**N**ebivolol, **B**etaxolol, **B**isoprolol, **A**tenolol, **E**smolol, **A**cebutolol, **M**etoprolol). * **Butoxamine Warning:** Because it blocks Beta-2 receptors, it can cause bronchoconstriction and inhibit glycogenolysis; therefore, it is contraindicated in patients with asthma or diabetes (though it is not used clinically). * **Non-selective Beta blockers:** Propranolol, Nadolol, Timolol, Pindolol. * **Mixed Alpha/Beta blockers:** Labetalol, Carvedilol.
Explanation: ### Explanation The correct answer is **D. More than 80% - 90%**. **1. Underlying Medical Concept: The Margin of Safety** Neuromuscular transmission possesses a significant **"Margin of Safety."** At the neuromuscular junction (NMJ), the amount of Acetylcholine (ACh) released per nerve impulse and the density of postsynaptic nicotinic receptors ($N_m$) far exceed what is minimally required to trigger a muscle action potential. For non-depolarizing neuromuscular blockers (like Atracurium or Vecuronium) to cause a failure in transmission (muscle paralysis), they must compete with ACh and occupy a vast majority of these receptors. Clinical relaxation only begins when approximately **70-80%** of receptors are blocked, and complete surgical paralysis (neuromuscular blockade) requires **more than 80-90%** receptor occupancy. **2. Analysis of Incorrect Options** * **Options A, B, and C:** These percentages are insufficient to overcome the physiological margin of safety. At these levels of blockade, the remaining free receptors (10-70%) are still more than enough to bind ACh and generate an end-plate potential strong enough to reach the threshold for muscle contraction. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **The "All-or-None" Threshold:** Transmission only fails when the end-plate potential falls below the threshold level. * **Fade Phenomenon:** Non-depolarizing blockers also block **pre-junctional nicotinic receptors**, which normally facilitate ACh release during high-frequency stimulation. This leads to the characteristic "fade" seen in the Train-of-Four (TOF) monitoring. * **Reversibility:** Because these are competitive antagonists, the blockade can be reversed by increasing the concentration of ACh using Acetylcholinesterase inhibitors like **Neostigmine**. * **Critical Level for Recovery:** A patient is generally considered safe for extubation when the TOF ratio is **>0.9**, indicating that less than 70% of receptors remain occupied.
Cholinergic Agonists
Practice Questions
Cholinergic Antagonists
Practice Questions
Adrenergic Agonists
Practice Questions
Adrenergic Antagonists
Practice Questions
Ganglionic Agents
Practice Questions
Neuromuscular Blocking Agents
Practice Questions
Autonomic Drugs in Ophthalmology
Practice Questions
Autonomic Drugs in Cardiovascular Disease
Practice Questions
Autonomic Drugs in Respiratory Disease
Practice Questions
Autonomic Drugs in Urological Disorders
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free